Ryan D Drant - Net Worth and Insider Trading

Ryan D Drant Net Worth

The estimated net worth of Ryan D Drant is at least $1.4 Billion dollars as of 2024-11-13. Ryan D Drant is the 10% Owner of Tesaro Inc and owns about 9,854,255 shares of Tesaro Inc (TSRO) stock worth over $739 Million. Ryan D Drant is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,608,912 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Ryan D Drant is also the 10% Owner of Echo Global Logistics Inc and owns about 2,420,219 shares of Echo Global Logistics Inc (ECHO) stock worth over $117 Million. Besides these, Ryan D Drant also holds Groupon Inc (GRPN) , Ardelyx Inc (ARDX) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Epizyme Inc (EPZM) , Dermira Inc (DERM) , Clovis Oncology Inc (CLVSQ) , Tableau Software Inc (DATA) , ARYx Therapeutics Inc (ARYX) . Details can be seen in Ryan D Drant's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ryan D Drant has not made any transactions after 2015-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ryan D Drant

Ryan D Drant Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ryan D Drant owns 32 companies in total, including Ardelyx Inc (ARDX) , Tesaro Inc (TSRO) , and TriVascular Technologies Inc (TRIV) among others .

Click here to see the complete history of Ryan D Drant’s form 4 insider trades.

Insider Ownership Summary of Ryan D Drant

Ticker	Comapny	Transaction Date	Type of Owner
ARDX	Ardelyx Inc	2015-06-05	10 percent owner
TSRO	Tesaro Inc	2015-06-01	10 percent owner
TRIV	TriVascular Technologies Inc	2015-05-22	director & 10 percent owner
		2015-03-11	10 percent owner
		2015-01-29	10 percent owner
		2015-01-26	10 percent owner
		2015-01-22	10 percent owner
		2014-12-23	10 percent owner
		2014-01-30	10 percent owner
		2014-12-02	10 percent owner
		2014-11-25	10 percent owner
		2014-10-08	10 percent owner
		2014-08-27	10 percent owner
		2014-08-15	10 percent owner
		2014-08-06	10 percent owner
		2014-07-22	10 percent owner
		2014-04-09	10 percent owner
		2014-04-02	10 percent owner
		2014-01-29	10 percent owner
		2013-05-22	10 percent owner
		2014-01-09	10 percent owner
		2013-10-29	10 percent owner
		2013-08-22	10 percent owner
		2011-11-21	10 percent owner
		2012-10-11	10 percent owner
		2012-10-29	10 percent owner
		2012-04-30	10 percent owner
		2012-03-28	10 percent owner
		2007-05-30	10 percent owner
		2009-10-01	10 percent owner
		2011-03-10	10 percent owner
		2009-04-03	10 percent owner

Ryan D Drant Latest Holdings Summary

Ryan D Drant currently owns a total of 12 stocks. Among these stocks, Ryan D Drant owns 9,854,255 shares of Tesaro Inc (TSRO) as of June 5, 2013, with a value of $739 Million and a weighting of 52.53%. Ryan D Drant owns 13,608,912 shares of iShares Indl/Office Real Estate Capped (FNIO) as of April 30, 2012, with a value of $434 Million and a weighting of 30.86%. Ryan D Drant also owns 2,420,219 shares of Echo Global Logistics Inc (ECHO) as of October 1, 2009, with a value of $117 Million and a weighting of 8.3%. The other 9 stocks Groupon Inc (GRPN) , Ardelyx Inc (ARDX) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Epizyme Inc (EPZM) , Dermira Inc (DERM) , Clovis Oncology Inc (CLVSQ) , Tableau Software Inc (DATA) , ARYx Therapeutics Inc (ARYX) have a combined weighting of 8.3% among all his current holdings.

Latest Holdings of Ryan D Drant

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TSRO	Tesaro Inc	2013-06-05	9,854,255	74.96	738,674,955
FNIO	iShares Indl/Office Real Estate Capped	2012-04-30	13,608,912	31.89	433,988,204
ECHO	Echo Global Logistics Inc	2009-10-01	2,420,219	48.24	116,751,365
GRPN	Groupon Inc	2013-08-22	3,709,248	11.32	41,988,687
ARDX	Ardelyx Inc	2015-06-05	7,489,485	4.59	34,376,736
INWK	InnerWorkings Inc	2012-02-29	6,029,555	2.99	18,028,369
MM	Millennial Media Inc	2012-10-29	8,196,614	1.75	14,344,075
EPZM	Epizyme Inc	2014-08-15	5,149,740	1.47	7,570,118
DERM	Dermira Inc	2014-10-02	17,241	18.75	323,269
CLVSQ	Clovis Oncology Inc	2011-11-21	3,419,671	0.02	51,295
DATA	Tableau Software Inc	2014-11-10	0	169.53	0
ARYX	ARYx Therapeutics Inc	2011-03-10	0	0.00	0

Holding Weightings of Ryan D Drant

Ryan D Drant Form 4 Trading Tracker

According to the SEC Form 4 filings, Ryan D Drant has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the sale of 4,163 shares on June 5, 2013, which brought Ryan D Drant around $163,023.

According to the SEC Form 4 filings, Ryan D Drant has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 16,101 shares on April 30, 2012, which brought Ryan D Drant around $427,160.

According to the SEC Form 4 filings, Ryan D Drant has made a total of 0 transactions in Echo Global Logistics Inc (ECHO) over the past 5 years. The most-recent trade in Echo Global Logistics Inc is the sale of 0 shares on October 1, 2009, which brought Ryan D Drant around $0.

More details on Ryan D Drant's insider transactions can be found in the Insider Trading History of Ryan D Drant table.

Insider Trading History of Ryan D Drant

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ryan D Drant Trading Performance

GuruFocus tracks the stock performance after each of Ryan D Drant's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ryan D Drant is 41.14%. GuruFocus also compares Ryan D Drant's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ryan D Drant within 3 months outperforms 5 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ryan D Drant's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ryan D Drant

Average Return

Average return per transaction

Outperforming Transactions

2 out of 5 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	9.11
Relative Return to S&P 500(%)	8.14

Ryan D Drant Ownership Network

Ownership Network List of Ryan D Drant

No Data

Ownership Network Relation of Ryan D Drant

Ryan D Drant Owned Company Details

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Ryan D Drant is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include director & President & CEO Michael Raab , Chief Development Officer David P. Rosenbaum , and Chief Medical Officer Laura A Williams .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 327,070 shares made by Michael Raab , a net sale of 301,515 shares made by David P. Rosenbaum , and a net sale of 490,778 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 298,239 shares of Ardelyx Inc (ARDX) in total and bought 0 shares, with a net sale of 298,239 shares. During the past 18 months, 1,971,512 shares of Ardelyx Inc (ARDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,971,512 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Ryan D Drant is the 10 percent owner of Tesaro Inc. Other key executives at Tesaro Inc include director & President & COO Mary Lynne Hedley , SVP & Chief Medical Officer Huber Martin H. Jr. , and director & Chief Executive Officer Moulder Leon O Jr .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

Ryan D Drant is the director & 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Patrick J Kerins , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Champions Oncology Inc do?

Who are the key executives at Champions Oncology Inc?

Ryan D Drant is the 10 percent owner of Champions Oncology Inc. Other key executives at Champions Oncology Inc include director & President Ronnie Morris , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Roger H Lee .

Champions Oncology Inc (CSBR) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in Champions Oncology Inc (CSBR). Other recent insider transactions involving Champions Oncology Inc (CSBR) include a net purchase of 75,504 shares made by Daniel Newman Mendelson ,

In summary, during the past 3 months, insiders sold 0 shares of Champions Oncology Inc (CSBR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Champions Oncology Inc (CSBR) were sold and 75,504 shares were bought by its insiders, resulting in a net purchase of 75,504 shares.

Champions Oncology Inc (CSBR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Champions Oncology Inc Insider Transactions

No Available Data

What does TRACON Pharmaceuticals Inc do?

Who are the key executives at TRACON Pharmaceuticals Inc?

Ryan D Drant is the 10 percent owner of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .

TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,200 shares.

TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.

TRACON Pharmaceuticals Inc Insider Transactions

No Available Data

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Ryan D Drant is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include director & Chief Executive Officer Steven Lo , Chief Financial Officer Christine Matthews , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zosano Pharma Corp Insider Transactions

No Available Data

What does Box Inc do?

Who are the key executives at Box Inc?

Ryan D Drant is the 10 percent owner of Box Inc. Other key executives at Box Inc include director & 10 percent owner & Chief Financial Officer Dylan C Smith , director & 10 percent owner & Chief Executive Officer Aaron Levie , and VP Chief Acct Ofr & Controller Eli Berkovitch .

Box Inc (BOX) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in Box Inc (BOX). Other recent insider transactions involving Box Inc (BOX) include a net sale of 221,000 shares made by Dylan C Smith , a net sale of 60,000 shares made by Aaron Levie , and a net sale of 21,550 shares made by Eli Berkovitch .

In summary, during the past 3 months, insiders sold 54,526 shares of Box Inc (BOX) in total and bought 0 shares, with a net sale of 54,526 shares. During the past 18 months, 485,496 shares of Box Inc (BOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 485,496 shares.

Box Inc (BOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Box Inc Insider Transactions

No Available Data

What does Interleukin Genetics Inc do?

Who are the key executives at Interleukin Genetics Inc?

Ryan D Drant is the 10 percent owner of Interleukin Genetics Inc. Other key executives at Interleukin Genetics Inc include 10 percent owner Patrick J Kerins , 10 percent owner Growth Equity Opportunities Fund III, LLC , and Interim CFO Stephen J. Dipalma .

Interleukin Genetics Inc (ILIU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interleukin Genetics Inc (ILIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interleukin Genetics Inc (ILIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interleukin Genetics Inc (ILIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Interleukin Genetics Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Ryan D Drant is the 10 percent owner of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Tableau Software Inc do?

Who are the key executives at Tableau Software Inc?

Ryan D Drant is the 10 percent owner of Tableau Software Inc. Other key executives at Tableau Software Inc include EVP & GC & Secretary Keenan Michael Conder , EVP & Product Development Mark Thomas Nelson , and Executive VP & Sales Kelly Wright .

Tableau Software Inc (DATA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tableau Software Inc (DATA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tableau Software Inc (DATA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tableau Software Inc (DATA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tableau Software Inc Insider Transactions

No Available Data

What does Cvent Inc do?

Who are the key executives at Cvent Inc?

Ryan D Drant is the 10 percent owner of Cvent Inc. Other key executives at Cvent Inc include Chief Financial Officer Cynthia A Russo , 10 percent owner Insight Venture Partners Vii, L.p. , and 10 percent owner Insight Venture Partners (delaware) Vii, L.p. .

Cvent Inc (CVT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cvent Inc (CVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cvent Inc (CVT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cvent Inc (CVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cvent Inc Insider Transactions

No Available Data

What does Dermira Inc do?

Who are the key executives at Dermira Inc?

Ryan D Drant is the 10 percent owner of Dermira Inc. Other key executives at Dermira Inc include director & Chief Medical Officer Eugene A Bauer , director & CEO & Chairman of the Board Thomas G Wiggans , and CFO Andrew Guggenhime .

Dermira Inc (DERM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dermira Inc (DERM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dermira Inc (DERM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dermira Inc (DERM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dermira Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Ryan D Drant is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Ryan D Drant is the 10 percent owner of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epizyme Inc Insider Transactions

No Available Data

What does Loxo Oncology Inc do?

Who are the key executives at Loxo Oncology Inc?

Ryan D Drant is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .

Loxo Oncology Inc (LOXO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Loxo Oncology Inc Insider Transactions

No Available Data

What does Sorrento Tech Inc do?

Who are the key executives at Sorrento Tech Inc?

Ryan D Drant is the 10 percent owner of Sorrento Tech Inc. Other key executives at Sorrento Tech Inc include 10 percent owner Orbimed Capital Gp Iii Llc , 10 percent owner Samuel D Isaly , and 10 percent owner Orbimed Advisors Llc .

Sorrento Tech Inc (ROKA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Tech Inc (ROKA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Tech Inc (ROKA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Tech Inc (ROKA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Tech Inc Insider Transactions

No Available Data

What does Opower Inc do?

Who are the key executives at Opower Inc?

Ryan D Drant is the 10 percent owner of Opower Inc. Other key executives at Opower Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Scott D Sandell , and 10 percent owner M James Barrett .

Opower Inc (OPWR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Opower Inc (OPWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opower Inc (OPWR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Opower Inc (OPWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opower Inc Insider Transactions

No Available Data

What does Aerohive Networks Inc do?

Who are the key executives at Aerohive Networks Inc?

Ryan D Drant is the 10 percent owner of Aerohive Networks Inc. Other key executives at Aerohive Networks Inc include VP & Gen. Counsel & Secretary Stephen Debenham , SVP & CFO & COO John Ritchie , and 10 percent owner Lightspeed General Partner Vii, L.p. .

Aerohive Networks Inc (HIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerohive Networks Inc (HIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerohive Networks Inc (HIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerohive Networks Inc (HIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerohive Networks Inc Insider Transactions

No Available Data

What does Care.com Inc do?

Who are the key executives at Care.com Inc?

Ryan D Drant is the 10 percent owner of Care.com Inc. Other key executives at Care.com Inc include 10 percent owner Ac/interactivecorp , 10 percent owner Capitalg Gp Llc , and 10 percent owner Alphabet Inc. .

Care.com Inc (CRCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Care.com Inc (CRCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Care.com Inc (CRCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Care.com Inc (CRCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Care.com Inc Insider Transactions

No Available Data

What does ChannelAdvisor Corp do?

Who are the key executives at ChannelAdvisor Corp?

Ryan D Drant is the 10 percent owner of ChannelAdvisor Corp. Other key executives at ChannelAdvisor Corp include director & Chief Executive Officer M Scot Wingo , Chief Operating Officer Elizabeth Segovia , and President and COO David J Spitz .

ChannelAdvisor Corp (ECOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChannelAdvisor Corp (ECOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChannelAdvisor Corp (ECOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChannelAdvisor Corp (ECOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChannelAdvisor Corp Insider Transactions

No Available Data

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Ryan D Drant is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 13,800 shares made by Brian M. Hahn .

In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,275,199 shares of GlycoMimetics Inc (GLYC) were sold and 387,903 shares were bought by its insiders, resulting in a net sale of 1,887,296 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlycoMimetics Inc Insider Transactions

No Available Data

What does Xoom Corp do?

Who are the key executives at Xoom Corp?

Ryan D Drant is the 10 percent owner of Xoom Corp. Other key executives at Xoom Corp include 10 percent owner Capital Xi Sequoia , 10 percent owner Sequoia Technology Partners Xi , and 10 percent owner Sequoia Capital Xi Principals Fund .

Xoom Corp (XOOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xoom Corp (XOOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xoom Corp (XOOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xoom Corp (XOOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xoom Corp Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

Ryan D Drant is the 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net purchase of 323,344 shares made by Dusan Senkypl , a net purchase of 15,000 shares made by Jason Harinstein , and a net sale of 4,583 shares made by Robert J Bass .

In summary, during the past 3 months, insiders sold 0 shares of Groupon Inc (GRPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,583 shares of Groupon Inc (GRPN) were sold and 338,344 shares were bought by its insiders, resulting in a net purchase of 333,761 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

Ryan D Drant is the 10 percent owner of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Paul Edward Gross , and See remarks Daniel W Muehl .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does Workday Inc do?

Who are the key executives at Workday Inc?

Ryan D Drant is the 10 percent owner of Workday Inc. Other key executives at Workday Inc include 10 percent owner David A Duffield , EVP & General Counsel & Secty Richard Harry Sauer , and Co-President Sayan Chakraborty .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 2,282,002 shares made by David A Duffield , a net sale of 30,871 shares made by Douglas A. Robinson , and a net sale of 57,562 shares made by Richard Harry Sauer .

In summary, during the past 3 months, insiders sold 591,978 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 591,978 shares. During the past 18 months, 2,524,211 shares of Workday Inc (WDAY) were sold and 8,676 shares were bought by its insiders, resulting in a net sale of 2,515,535 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does Millennial Media Inc do?

Who are the key executives at Millennial Media Inc?

Ryan D Drant is the 10 percent owner of Millennial Media Inc. Other key executives at Millennial Media Inc include VP & Controller & Treasurer Lara Sweet , director & President Robert Lord , and 10 percent owner Verizon Communications Inc .

Millennial Media Inc (MM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millennial Media Inc (MM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millennial Media Inc (MM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millennial Media Inc (MM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millennial Media Inc Insider Transactions

No Available Data

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Ryan D Drant is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include director & President & CEO Jack A. Khattar , Sr VP & Quality & GMP Oper. & IT Frank Mottola , and Sr. VP of IP & CSO Padmanabh P. Bhatt .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 98,505 shares made by Padmanabh P. Bhatt , a net sale of 21,235 shares made by Tami Tillotson Martin , and a net sale of 28,099 shares made by Georges Gemayel .

In summary, during the past 3 months, insiders sold 168,099 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 168,099 shares. During the past 18 months, 300,542 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 300,542 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Ryan D Drant is the 10 percent owner of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Ryan D Drant is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 232,762 shares made by Bradley L Campbell , a net sale of 333,235 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 803,781 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 803,781 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Ryan D Drant is the 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Ryan D Drant is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Ryan D Drant is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Ryan D Drant made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 14,272 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,272 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 85,728 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

Ryan D Drant Mailing Address

Above is the net worth, insider trading, and ownership report for Ryan D Drant. You might contact Ryan D Drant via mailing address: 1119 St Paul Street, Baltimore Md 21202.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.